michigandaily.com
Thursday, May 10, 2018
INDEX
Vol. CXXVII, No. 116 | © 2018 The Michigan Daily
michigandaily.com
NEWS ....................................
OPINION ...............................
ARTS ......................................
MiC.........................................
SPORTS................................
MICHIGAN IN COLOR
Defend DACA
Immigrant protections
are at risk under Donald
Trump
>> SEE PAGE 9
NEWS
Racist list update
University investigation of
crass and racist Elite Bar
Crawl list is at a stand still.
>> SEE PAGE 2
OPINION
Let’s Make a Pact
Hannah Harshe explores how
different standards are set for
men and women at work.
>> SEE PAGE 5
ARTS
‘This is America’
Childish Gambino
releases confrontational
new single.
>> SEE PAGE 7
SPORTS
Softball prevails
over Ohio State
On Senior Day, the
Michgan softball team
defeated its biggest rival
>> SEE PAGE 12
inside
2
4
6
9
10
See RESEARCH, Page 3
U-M sued by Speech First
over Bias Response Team
Organization files
injunction against
“U” over free speech
By GRACE KAY
Summer Managing News Editor
The University of Michigan is
the first university in the nation to
receive a federal lawsuit regarding
the effect the U-M Bias Response
Team might have on speech
freedom on campus.
On Tuesday, Speech First, an
organization of students, citizens
and alumni advocating free speech
on college campuses, filed a federal
lawsuit against the University,
challenging the Bias Response
Team’s accordance with the U.S.
Constitution and calling for a
permanent injunction prohibiting
the Bias Response Team from
investigating students.
Speech First President Nicole
Neily said the organization is
filing the injunction against the
University based on three main
factors.
“We have multiple members of
the organization at the University,”
Neily said. “The University of
Michigan also has a combination
of a very bad speech code that
is very vague, a very active bias
response team that is very proud of
its achievements because it keeps
a log and we have numbers there,
though not all were listed in the
complaint. These were the three
things we needed.”
This is not the first time the
University’s
speech
code
and
freedom of speech has been called
into question. In 2017, hundreds of
students flooded into the Michigan
League to voice displeasure with
the Michigan Political Union’s
decision to debate the Black Lives
Matter movement as harmful to
racial relations, causing many
people outside of the University
to question whether unpopular
voices or perspectives can be
heard at the University. Similarly,
when Charles Murray, author of
“The Bell Curve,” a book which
argues for the concept of racial
differences in intelligence, spoke
at the University, several students
attempted to shut down the event.
The University has experienced
controversy on the speech code
as far back as 1989. A 1989 case,
Doe v. University of Michigan,
determined the University’s 1988
hate speech law violated the
constitutional right to free speech.
Neily claims freedom of speech
and the campus atmosphere are
stifled by vague and subjective
speech codes and bias response
teams.
“It is very difficult to have a
system in place (like a bias response
team) without having a mechanism
that kills speech,” Neily said. “I fail
to see how you can have that kind
of system without entirely stifling
free speech.”
According to the University’s
Bias Response Team website,
a bias incident is anything that
discriminates against a community
based on their identity.
New pill
can detect
breast cancer
Researchers at “U”
develop pill to reduce
overtreatment
By NATSAHA PIETRUSCHKA
Daily Staff Reporter
Researchers at the University of
Michigan are developing a new diagnostic
pill that improves conventional detection
methods and reduces the overtreatment
of breast cancer. The U-M research
team, led by Greg Thurber, chemical
engineering
assistant
professor,
is
refining an oral pill that dissolves in the
bloodstream and illuminates tumors
under infrared light.
According to Thurber, many women
who have breast cancer tumors would
never suffer from the disease but are
treated
anyway.
Mammography,
a
common form of breast cancer detection,
determines the existence of a tumor but
not if the tumor is cancerous or benign.
Chemicals in the new pill are able to bind
to cancerous tissue and light up under
infrared light to inform physicians where
cancerous tumors are located.
Thurber
says
that
knowing
information at the molecular level is at
the core of effective cancer detection.
“We’ve known from decades of
research in cancer biology that it’s really
a molecular disease, so what’s nice about
our approach is that you’re actually
getting molecular information,” Thurber
said.
The
pill
is
an
alternative
to
mammograms or other methods such
as magnetic resonance imaging and
ultrasounds. According to Thurber,
mammograms
can
sometimes
be
inaccurate, as they may miss tumors in
women with dense breast tissue.
Thurber believes his team’s method
would be useful at spotting tumors in
patients where mammograms don’t work
well.
See LAWSUIT, Page 3
DANYEL THARAKAN / DAILY
ONE-HUNDRED-TWENTY SEVEN YEARS OF EDITORIAL FREEDOM
RESEARCH